OTCMKTS:RTOKY - Rentokil Initial Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 10
  • Breakdown:
  • 2 Sell Ratings
  • 1 Hold Ratings
  • 7 Buy Ratings
  • 0 Strong Buy Ratings
$42.09
▲ +0.56 (1.35%)

This chart shows the closing price for RTOKY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Rentokil Initial Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RTOKY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RTOKY

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 10 analysts offering 12 month price targets for Rentokil Initial in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $42.09.

This chart shows the closing price for RTOKY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 10 polled investment analysts is to buy stock in Rentokil Initial. This rating changed within the last month from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
5/2/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 0 sell ratings
7/31/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 2 hold ratings
  • 1 sell ratings
10/29/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 2 hold ratings
  • 1 sell ratings
1/27/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 2 hold ratings
  • 2 sell ratings
4/27/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 2 hold ratings
  • 2 sell ratings
7/26/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 2 hold ratings
  • 2 sell ratings
9/24/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 2 sell ratings
10/24/2021

Latest Recommendations

  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 2 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/21/2021Peel HuntDowngradeHold
10/7/2021Morgan StanleyReiterated RatingOverweight
8/4/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
7/30/2021BarclaysReiterated RatingOverweight
7/30/2021Royal Bank of CanadaReiterated RatingOutperform
7/14/2021Berenberg BankReiterated RatingSell
3/29/2021BNP ParibasUpgradeNeutral ➝ Outperform
3/29/2021Exane BNP ParibasUpgradeNeutral ➝ Outperform
3/12/2021Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy
3/10/2021UBS GroupReiterated RatingSell
3/5/2021Morgan StanleyReiterated RatingOverweight
3/4/2021Peel HuntUpgradeHold
2/2/2021Berenberg BankInitiated CoverageSell
1/14/2021JPMorgan Chase & Co.Reiterated RatingOverweight
1/12/2021Morgan StanleyReiterated RatingOverweight
10/23/2020BarclaysReiterated RatingOverweight
10/8/2020JPMorgan Chase & Co.Reiterated RatingOverweight
10/5/2020The Goldman Sachs GroupDowngradeBuy ➝ Neutral
9/21/2020UBS GroupInitiated CoverageSell
8/27/2020Morgan StanleyReiterated RatingOverweight
8/7/2020JPMorgan Chase & Co.Reiterated RatingOverweight
8/3/2020Morgan StanleyReiterated RatingOverweight
7/24/2020Deutsche Bank AktiengesellschaftReiterated RatingHold
7/17/2020The Goldman Sachs GroupReiterated RatingBuy
6/26/2020JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight
6/22/2020Credit Suisse GroupUpgradeNeutral ➝ Outperform
5/4/2020Morgan StanleyInitiated CoverageOverweight
4/17/2020Credit Suisse GroupReiterated RatingNeutral
4/1/2020Deutsche Bank AktiengesellschaftReiterated RatingHold
3/26/2020JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral
3/25/2020The Goldman Sachs GroupUpgradeNeutral ➝ Buy
3/19/2020HSBCDowngradeBuy ➝ Hold
2/24/2020Jefferies Financial GroupUpgradeHold ➝ Buy
1/7/2020Credit Suisse GroupDowngradeOutperform ➝ Neutral
2/1/2019CitigroupUpgradeNeutral ➝ Buy
1/25/2019Peel HuntUpgradeHold ➝ Add
1/21/2019The Goldman Sachs GroupDowngradeBuy ➝ Neutral
4/16/2018Deutsche Bank AktiengesellschaftReiterated RatingBuy ➝ Hold
3/2/2018Jefferies Financial GroupUpgradeHold ➝ Buy
(Data available from 10/24/2016 forward)

News Sentiment Rating

0.11 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/28/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/27/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/27/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/26/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/26/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/25/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/24/2021
  • 0 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
10/24/2021

Current Sentiment

  • 0 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Rentokil Initial logo
Rentokil Initial Plc engages in the provision of business support services. The firm through its products and services protect people from the dangers of pest-borne disease and the risks of poor hygiene. It operates through the following geographical segments: France, Benelux, Germany, Southern Europe, and Latin America. The firm focuses on route-based services, predominately in pest control and hygiene as well as other smaller specialist services including plants, medical services, property care and specialist hygiene. The company was founded by Harold Maxwell-Lefroy on September 29, 1924 and is headquartered in Camberley, the United Kingdom.
Read More

Today's Range

Now: $42.09
Low: $41.50
High: $42.11

50 Day Range

MA: $40.88
Low: $39.37
High: $43.06

52 Week Range

Now: $42.09
Low: $32.42
High: $43.06

Volume

10,626 shs

Average Volume

35,037 shs

Market Capitalization

$15.65 billion

P/E Ratio

42.95

Dividend Yield

0.60%

Beta

0.77

Frequently Asked Questions

What sell-side analysts currently cover shares of Rentokil Initial?

The following Wall Street analysts have issued stock ratings on Rentokil Initial in the last year: Barclays PLC, Berenberg Bank, BNP Paribas, Deutsche Bank Aktiengesellschaft, Exane BNP Paribas, JPMorgan Chase & Co., Morgan Stanley, Peel Hunt, Royal Bank of Canada, UBS Group AG, and Zacks Investment Research.
View the latest analyst ratings for RTOKY.

What is the current price target for Rentokil Initial?

0 Wall Street analysts have set twelve-month price targets for Rentokil Initial in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Rentokil Initial in the next year.
View the latest price targets for RTOKY.

What is the current consensus analyst rating for Rentokil Initial?

Rentokil Initial currently has 2 sell ratings, 1 hold rating and 7 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe RTOKY will outperform the market and that investors should add to their positions of Rentokil Initial.
View the latest ratings for RTOKY.

What other companies compete with Rentokil Initial?

How do I contact Rentokil Initial's investor relations team?

Rentokil Initial's physical mailing address is Riverbank Meadows Business Park, Camberley X0, GU17 9AB. The business services provider's listed phone number is 441276607444 and its investor relations email address is [email protected] The official website for Rentokil Initial is www.rentokil-initial.com.